bioRxivGeneticsPreprint
Human iPSC-derived RPE and retinal organoids reveal impaired alternative splicing of genes involved in pre-mRNA splicing in PRPF31 autosomal dominant retinitis pigmentosa
Adriana BuskiniD, Lili ZhuiD, Valeria ChichagovaiD, Basudha BasuiD, Sina Mozaffari‐JoviniD, David DolaniD, Alastair DroopiD, Joseph Collin, Revital BronsteiniD, Sudeep MehrotraiD, Michael H. FarkasiD, Gerrit HilgeniD, Kathryn WhiteiD, Dean HallamiD, Katarzyna BialasiD, Git Chung, Carla MelloughiD, Yuchun DingiD, Natalio KrasnogoriD, Stefan Alexander PrzyborskiiD, Jumana Yousuf Al-AamaiD, Sameer AlharthiiD, Yaobo XuiD, Gabrielle WhewayiD, Katarzyna SzymańskaiD, , Majlinda LakoiD
Abstract
Mutations in pre-mRNA processing factors (PRPFs) cause 40% of autosomal dominant retinitis pigmentosa (RP), but it is unclear why mutations in ubiquitously expressed PRPFs cause retinal disease. To understand the molecular basis of this phenotype, we have generated RP type 11 (PRPF31-mutated) patient-specific retinal organoids and retinal pigment epithelium (RPE) from induced pluripotent stem cells (iPSC). Impaired alternative splicing of genes encoding pre-mRNA splicing proteins occurred in patient-specific retinal cells and Prpf31+/- mouse retinae, but not fibroblasts and iPSCs, providing mechanistic insights into retinal-specific phenotypes of PRPFs. RPE was the most affected, characterised by loss of apical-basal polarity, reduced trans-epithelial resistance, phagocytic capacity, microvilli, and cilia length and incidence. Disrupted cilia morphology was observed in patient-derived-photoreceptors that displayed progressive features associated with degeneration and cell stress. In situ gene-editing of a pathogenic mutation rescued key structural and functional phenotypes in RPE and photoreceptors, providing proof-of-concept for future therapeutic strategies.\n\neTOCPRPF31 is a ubiquitously expressed pre-mRNA processing factor that when mutated causes autosomal dominant RP. Using a patient-specific iPSC approach, Buskin and Zhu et al. show that retinal-specific defects result from altered splicing of genes involved in the splicing process itself, leading to impaired splicing, loss of RPE polarity and diminished phagocytic ability as well as reduced cilia incidence and length in both photoreceptors and RPE.\n\nHighlightsO_LISuccessful generation of iPSC-derived RPE and photoreceptors from four RP type 11 patients\nC_LIO_LIRPE cells express the mutant PRPF31 protein and show the lowest expression of wildtype protein\nC_LIO_LIPRPF31 mutations result in altered splicing of genes involved in pre-mRNA splicing in RPE and retinal organoids\nC_LIO_LIPrpf31 haploinsufficiency results in altered splicing of genes involved in pre-mRNA splicing in mouse retina\nC_LIO_LIRPE cells display loss of polarity, reduced barrier function and phagocytosis\nC_LIO_LIPhotoreceptors display shorter and fewer cilia and degenerative features\nC_LIO_LIRPE cells display most abnormalities suggesting they might be the primary site of pathogenesis\nC_LIO_LIIn situ gene editing corrects the mutation and rescues key phenotypes\nC_LI
- organism: human
- assay: scRNA-seq
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
- Citations
- 5
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Progressive protein aggregation in PRPF31 patient retinal pigment epithelium cells: the mechanism and its reversal through activation of autophagy
M. Georgiou, C. Yang, … M. Lako·bioRxiv·Oct 11, 2021
- Cell-autonomous restoration of splicing homeostasis and RP11 phenotype in patient-derived RPE and retinal organoids by PRPF31.AAV gene therapy
Maria Elia, Valda Pauzuolyte, … Majlinda Lako·bioRxiv·Apr 16, 2026
- AAV-mediated gene augmentation therapy restores critical functions in mutant iPSC-derived PRPF31+/- cells.
Elizabeth M. Brydon, Revital Bronstein, … Rosario Fernández‐Godino·Molecular Therapy — Methods & Clinical DevelopmentPeer-reviewed·Nov 11, 2019
- PRPF8-associated retinitis pigmentosa variant induces human neural retina-autonomous photoreceptor defects
Felix Zimmann, Poulami Banik, … David Staněk·Scientific ReportsPeer-reviewed·Feb 23, 2026
- The splicing regulator Prp31 prevents retinal degeneration in Drosophila by regulating Rhodopsin levels
Malte Lehmann, Sarita Hebbar, … Elisabeth Knust·bioRxiv·Aug 13, 2018
- Energetic failure and oxidative stress underlie the Prpf31 splicing factor-related mouse phenotype
Abdallah Hamieh, Elora M. Vanoni, … Emeline F. Nandrot·bioRxiv·Feb 28, 2025